Advertisement|Remove ads.

Shares of Assertio Holdings, Inc. (ASRT) fell 1.5% after hours on Wednesday after the company said that it has entered into an agreement to be acquired by Garda Therapeutics for a total cash consideration of $125.1 million.
Under the deal, Garda will pay Assertio shareholders $18 per share in cash and a contingent value right. The cash consideration represents a 3% discount to the stock’s closing price on Tuesday.
The transaction is expected to close in the second quarter of 2026 and is subject to customary closing conditions, the pharmaceutical company said.
Get updates to this developing story directly on Stocktwits.